FeesSafety
Pluang+

Solana co-founder clarifies BULK operates outside Solana's layer-1 despite collateral from multiple blockchains.

Market News
29 Oct 2026, 16:56 WIB
Tokenpost
View Source
Neutral
Solana co-founder clarifies BULK operates outside Solana's layer-1 despite collateral from multiple blockchains.

Solana co-founder Anatoly Yakovenko stated that projects not operating on Solana's layer-1 (L1) are considered separate networks, responding to BULK founder kdot's proposal to use collateral from four blockchains in one trading system. BULK's architecture involves an L0 execution layer working alongside Solana validators, separating trade execution from asset custody and settlement handled by Solana. Yakovenko emphasized that using collateral from other networks does not mean BULK's execution occurs on Solana's L1 and expressed focus on his own product. The collateral integration proposal has no set deployment date yet.

Solana co-founder Anatoly Yakovenko's comments provide context for readers. For those following major cryptocurrencies on Pluang, as of Oct 29, 2026 20:05 WIB, 19 of 50 major cryptocurrencies rose while 30 fell. Notable movers include BAL at Rp16.297 with an 11.14% increase and EOS at Rp12.649 with an 8.13% increase, while BCH dropped 5.42% to Rp5.091.612 with a 42% sell and 58% buy order split.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App